The suppression of immune activation during enfuvirtide-based salvage therapy is associated with reduced CCR5 expression and decreased concentrations of circulating interleukin-12 and IP-10 during 48 weeks of longitudinal follow-up.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples